Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Today’s New York TImes Magazine has a big article about Dr. Alexander Shulgin, who invented more than 100 hallucinogens and was, in all likelihood, the first person to try Ecstasy (MDMA) in humans. Shulgin is a really good guy, he’s previously been a consultant for the DEA, and he’s got a wicked-cool lab in California that I’ve visited on multiple occasions. Even if you’re not interested by psychedelic drugs, you should read this article — because Ecstasy is increasingly being put into trials as a possible cure for PTSD and other psychological disorders.

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me